First Page | Document Content | |
---|---|---|
![]() Date: 2015-07-10 15:12:35Myeloproliferative neoplasm Patient advocacy Essential thrombocytosis Microsoft Push Notification Service Caregiver Polycythemia vera | Add to Reading List |
![]() | NOMINATION FORM FOR MPN HEROES NOMINATION FORM FOR MPN HEROESDocID: 1oHQS - View Document |
![]() | 1 Dr Jürgen Thiele Institute for Pathology University of Cologne Kerpener Str. 62DocID: 1ohLr - View Document |
![]() | 1 Dr James Vardiman Professor Emeritus Department of Pathology University of ChicagoDocID: 1o8ES - View Document |
![]() | Registered PM (EN) 09-Mar-2015: Administrative NDS - Company name change (New 3D version to include the Submission Control No)DocID: 1lIPi - View Document |
![]() | Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, RichardDocID: 19YPO - View Document |